The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
Open accessAbstract
Dilated cardiomyopathy (DCM) is one of the most common causes of heart failure, and the underlying mechanism remains largely elusive. Here we investigated whether NLRP3 inflammasome-mediated pyroptosis contributes to non-ischemic DCM and dissected the underlying mechanism. We found that hyper activated NLRP3 inflammasome with pyroptotic cell death of cardiomyocytes were presented in the myocardial tissues of DCM patients, which were negatively correlated with cardiac function. Doxorubicin (Dox)-induced DCM characterization disclosed that NLRP3 inflammasome activation and pyroptosis occurred in Dox-treated heart tissues, but were very marginal in either NLRP3−/− or caspase-1−/− mice. Mechanistically, Dox enhanced expressions of NOX1 and NOX4 and induced mitochondrial fission through dynamin-related protein 1 (Drp1) activation, leading to NLRP3 inflammasome-mediated pyroptosis in cardiomyocytes via caspase-1-dependent manner. Conversely, both inhibitions of NOX1 and NOX4 and Drp1 suppressed Dox-induced NLPR3 inflammasome activation and pyroptosis. The alterations of NOX1 and NOX4 expression, Drp1 phosphorylation and mitochondrial fission were validated in DCM patients and mice. Importantly, Dox-induced Drp1-mediated mitochondrial fission and the consequent NLRP3 inflammasome activation and pyroptosis were reversed by NOX1 and NOX4 inhibition in mice. This study demonstrates for the first time that cardiomyocyte pyroptosis triggered by NLRP3 inflammasome activation via caspase-1 causally contributes to myocardial dysfunction progression and DCM pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · cited 5×
“Followed NLRP3 inflammasome activation, the mature forms of IL-1β and IL-18 release through the GSDMD pores, which may initiate and expand inflammation and result in cardiac injury in DCM.”
BackgroundInfluentialApoptosis in Myocytes in End-Stage Heart Failure
Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., & Khaw, B.-A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351603 · Cited by 1,430
Pro-inflammatory programmed cell death
Cookson, B. T., & Brennan, M. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01936-3 · Cited by 1,414
Wang, Y., Xu, C.-F., Liu, Y.-J., Mao, Y.-F., Lv, Z., Li, S.-Y., Zhu, X.-Y., & Jiang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477112 · Cited by 825
Abderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T., & Rouis, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.008 · Cited by 732
The NLRP3 inflammasome in acute myocardial infarction
Toldo, S., & Abbate, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.161 · Cited by 665
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
Yao, C., Veleva, T., Scott, L., Cao, S., Li, L., Chen, G., Jeyabal, P., Pan, X., Alsina, K. M., Abu-Taha, I., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035202 · Cited by 653
Weintraub, R. G., Semsarian, C., & Macdonald, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31713-5 · Cited by 649
Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis
Wu, X., Zhang, H., Qi, W., Zhang, Y., Li, J., Li, Z., Lin, Y., Bai, X., Liu, X., Chen, X., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0257-3 · Cited by 586
Signaling Pathways in Reactive Oxygen Species–Induced Cardiomyocyte Apoptosis
von Harsdorf, R., Li, P.-F., & Dietz, R. (1999) · Circulation · doi:10.1161/01.cir.99.22.2934 · Cited by 571
Dynamic regulation of mitochondrial fission through modification of the dynamin‐related protein Drp1
Chang, C., & Blackstone, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05629.x · Cited by 567
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
Cell death in the host response to infection
Labbé, K., & Saleh, M. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.91 · Cited by 392
Cesselli, D., Jakoniuk, I., Barlucchi, L., Beltrami, A. P., Hintze, T. H., Nadal-Ginard, B., Kajstura, J., Leri, A., & Anversa, P. (2001) · Circulation Research · doi:10.1161/hh1501.094115 · Cited by 378
Liu, Z., Gan, L., Xu, Y., Luo, D., Ren, Q., Wu, S., & Sun, C. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12414 · Cited by 361
(2016) · Encyclopedia of Immunotoxicology · doi:10.1007/978-3-642-54596-2_200383 · Cited by 306
Role of Pyroptosis in Cardiovascular Diseases and its Therapeutic Implications
Zeng, C., Wang, R., & Tan, H. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33568 · Cited by 283
Self-citationMantawy, E. M., El-Bakly, W. M., Esmat, A., Badr, A. M., & El-Demerdash, E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.065 · Cited by 259
Li, M., Sala, V., De Santis, M. C., Cimino, J., Cappello, P., Pianca, N., Di Bona, A., Margaria, J. P., Martini, M., Lazzarini, E., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030352 · Cited by 207
NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
Takahashi, M. (2014) · International Heart Journal · doi:10.1536/ihj.13-388 · Cited by 199
Sauter, K. A. D., Wood, L. J., Wong, J., Iordanov, M., & Magun, B. E. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.12.15540 · Cited by 194
Dargani, Z. T., & Singla, D. K. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00056.2019 · Cited by 159
Wang, R., Wang, Y., Mu, N., Lou, X., Li, W., Chen, Y., Dong, F., & Tan, H. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.30 · Cited by 147
Self-citationXia, Y., Chen, Z., Chen, A., Fu, M., Dong, Z., Hu, K., Yang, X., Zou, Y., Sun, A., Qian, J., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.06.003 · Cited by 143
Thandavarayan, R. A., Giridharan, V. V., Arumugam, S., Suzuki, K., Ko, K. M., Krishnamurthy, P., Watanabe, K., & Konishi, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119214 · Cited by 133
The phosphorylation state of Drp1 determines cell fate
Jahani‐Asl, A., & Slack, R. S. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401077 · Cited by 107
Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy
Iwata, Y., Ohtake, H., Suzuki, O., Matsuda, J., Komamura, K., & Wakabayashi, S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt163 · Cited by 87
The Role of Cell Death in the Pathogenesis of SLE : Is Pyroptosis the Missing Link?
Magna, M., & Pisetsky, D. S. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12335 · Cited by 84
Zhang, L., Huang, S., Ma, X., Zhang, W., Wang, D., Jin, S., Zhang, Y., Li, Y., & Li, X. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.014 · Cited by 82
Chen, Y., Pat, B., Gladden, J. D., Zheng, J., Powell, P. C., Wei, C., Cui, X., Husain, A., & Dell’Italia, L. J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01104.2010 · Cited by 77
Cantu, E., Lederer, D. J., Meyer, K. C., Milewski, K., Suzuki, Y., Shah, R., Diamond, J. M., Meyer, N. J., Tobias, J. W., Baldwin, D. A., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12283 · Cited by 74
Increased circulating interleukin-18 in patients with congestive heart failure
Naito, Y. (2002) · Heart · doi:10.1136/heart.88.3.296 · Cited by 62
Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM
Hong, Y. J., Kim, T. K., Hong, D., et al. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.12.018 · Cited by 61
Napoli, P. D., Taccardi, A. A., Grilli, A., Felaco, M., Balbone, A., Angelucci, D., Gallina, S., Calafiore, A. M., Caterina, R. D., & Barsotti, A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00445-9 · Cited by 57
Luo, B., Wang, F., Li, B., Dong, Z., Liu, X., Zhang, C., & An, F. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0600 · Cited by 35
Self-citationIbe, W., Saraste, A., Lindemann, S., Bruder, S., Buerke, M., Darius, H., Pulkki, K. J., & Voipio‐Pulkki, L. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.06.002 · Cited by 32
Pharmacologic Strategies to Target Oxidative Stress in Heart Failure
Ahmed, Z. U., & Tang, W. H. W. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-011-0081-5 · Cited by 31
Leontyev, S., Schlegel, F., Spath, C., Schmiedel, R., Nichtitz, M., Boldt, A., Rübsamen, R., Salameh, A., Kostelka, M., Mohr, F., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs200 · Cited by 26
Apoptosis in Endomyocardial Biopsies from Patients with Dilated Cardiomyopathy
Glumac, S., Pejić, S., Kostadinović, S., Stojšić, Z., & Vasiljević, J. (2016) · Folia Biologica · doi:10.14712/fb2016062050207 · Cited by 6
Cited by
The NLRP3 inflammasome: contributions to inflammation-related diseases
Chen, Y., Ye, X., Escames, G., Lei, W., Zhang, X., Li, M., Jing, T., Yao, Y., Qiu, Z., Wang, Z., et al. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00462-9 · Cited by 492
Self-citationPyroptosis: a new paradigm of cell death for fighting against cancer
Tan, Y., Chen, Q., Li, X., Zeng, Z., Xiong, W., Li, G., Li, X., Yang, J., Xiang, B., & Yi, M. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01959-x · Cited by 467
Kong, C.-Y., Guo, Z., Song, P., Zhang, X., Yuan, Y.-P., Teng, T., Yan, L., & Tang, Q.-Z. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65258 · Cited by 412
Self-citationThe role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
Toldo, S., & Abbate, A. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00946-3 · Cited by 411
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Liu, Y., Pan, R., Ouyang, Y., Gu, W., Xiao, T., Yang, H., Tang, L., Wang, H., Xiang, B., & Chen, P. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01958-2 · Cited by 337
Metadata
- Authors
- Zeng, C., Duan, F., Hu, J., Luo, B., Huang, B., Lou, X., Sun, X., Li, H., Zhang, X., Yin, S., & Tan, H.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 34
- Pages
- 101523
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W3014424278
- Cited by
- 384
- References
- 41
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.